ZNF586 can engage in various molecular interactions that result in the functional upregulation of the protein's activity. Bisphenol A, for instance, can bind to estrogen receptors, which have a relationship with the zinc finger domain of ZNF586. This interaction can induce ZNF586's DNA binding activity, thereby activating its role in transcriptional regulation. Similarly, Tamoxifen, by acting as an estrogen receptor modulator, can instigate conformational changes that amplify ZNF586's capacity to bind to DNA. Trichostatin A, through its inhibition of histone deacetylases, can increase acetylation levels near ZNF586's DNA binding sites, which might enhance the protein's transcriptional activation capabilities. Furthermore, 5-Azacytidine can reduce DNA methylation, potentially enabling ZNF586 to access and activate its target genes more efficiently.
Retinoic acid can activate retinoic acid receptors that may synergize with ZNF586 to activate gene expression. Genistein's inhibition of tyrosine kinases can lead to an elevated phosphorylation of associated proteins, thereby facilitating ZNF586's activation. Forskolin, through the elevation of cAMP levels, can activate protein kinase A, which in turn can enhance the phosphorylation and activation of ZNF586-associated proteins. Phorbol 12-myristate 13-acetate (PMA) can activate protein kinase C, which may phosphorylate and activate proteins that associate with ZNF586. Dexamethasone's interaction with glucocorticoid receptors can lead to structural changes that enhance ZNF586's activity, while Lithium chloride's inhibition of GSK-3β can increase the activity of proteins like β-catenin, which may work in concert with ZNF586 to co-activate transcription. Sodium butyrate, by inhibiting histone deacetylases, can create a chromatin environment conducive to ZNF586-mediated gene activation. Lastly, Curcumin's ability to inhibit NF-κB can alleviate repression on genes, thus permitting ZNF586 to bind and activate their expression more effectively. Each of these chemicals thereby facilitates the activation of ZNF586's role in gene regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
Bisphenol A binds to estrogen receptors which are known to interact with the zinc finger domain of ZNF586, leading to an activation of its DNA binding activity. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $256.00 | 18 | |
Tamoxifen acts as an estrogen receptor modulator and can result in conformational changes that enhance ZNF586 binding to DNA, thereby activating its function. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A inhibits histone deacetylases which can increase acetylation of histones near the ZNF586 binding sites, enhancing its ability to bind DNA and activate transcriptional activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine inhibits DNA methyltransferases, potentially leading to hypomethylation of DNA at sites where ZNF586 may bind, thus facilitating its activation of gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid activates retinoic acid receptors which can form heterodimers with other transcription factors that recruit ZNF586 to DNA, leading to activation of target gene expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein is a tyrosine kinase inhibitor which may enhance phosphorylation status of proteins interacting with ZNF586, leading to an increase in ZNF586's DNA binding and activation potential. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which can activate PKA and potentially enhance phosphorylation of proteins that associate with ZNF586, promoting its activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC) which could phosphorylate and alter the function of proteins that associate with ZNF586, hence activating ZNF586. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone binds to glucocorticoid receptors which may interact with ZNF586, resulting in allosteric changes that enhance ZNF586's activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3β, potentially leading to increased stability and activity of β-catenin, a protein which may interact with ZNF586 to co-activate transcriptional programs. | ||||||